Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


World’s Biggest L-DOPA Production Base Ready For Operation

This article was originally published in PharmAsia News

Executive Summary

Shandong Xinhua Pharmaceutical Co. Ltd. and Sankyo Chemical Industries Ltd. held a completion ceremony for their joint L-380 (drug name L-DOPA) project in Zibo city, Shandong province on Dec. 23. Initial production is to begin in early 2008 with a yearly output of 300 tonnes. The project will be the world's biggest L-380 production base when in full operation. L-DOPA, used for treating Parkinson's disease, is expected to grow at an annual rate of 13 percent globally to reach $2.3 billion by 2010. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts